Advertisement
Screener

SES AI Corporation (SES) Spending and interest coverage

SES AI Corporation (SES) Spending and interest coverage

  • R&D / revenue · 12 months: Value 212.42%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 35.75%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months212.42%Research and development expense / revenue. Period ending 2026-06-30.

$49.84M ÷ $23.46M × 100 ≈ 212.42%

Stock-based compensation / revenue · 12 months35.75%Share-based compensation / revenue. Period ending 2026-06-30.

$8.39M ÷ $23.46M × 100 ≈ 35.75%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending49.84M USDResearch and Development Expense
Revenue23.46M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation8.39M USDShare-based Payment Arrangement, Noncash Expense
Operating income-73.40M USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$49.84M$23.46M$8.39M$-73.40M(m)212.42%35.75%(m)(m)
2026-03-31$57.57M$21.92M$9.11M$-77.21M(m)262.64%41.58%(m)(m)
2025-12-31$67.05M$21.00M$10.97M$-82.61M(m)319.26%52.24%(m)(m)
2025-09-30$76.10M(m)$12.70M$-94.06M(m)(m)(m)(m)(m)
2025-06-30$84.92M(m)$17.04M$-109.63M(m)(m)(m)(m)(m)
2025-03-31$80.89M(m)$19.12M$-111.25M(m)(m)(m)(m)(m)
2024-12-31$72.14M$2.04M$19.93M$-109.25M(m)3536.32%977.21%(m)(m)
2024-09-30$58.63M(m)$20.54M$-98.03M(m)(m)(m)(m)(m)
2024-06-30$42.66M(m)$16.45M$-83.17M(m)(m)(m)(m)(m)
2024-03-31$33.95M(m)$18.97M$-77.82M(m)(m)(m)(m)(m)
2023-12-31$30.68M(m)$20.65M$-78.16M(m)(m)(m)(m)(m)
2023-09-30$31.59M(m)$23.03M$-79.83M(m)(m)(m)(m)(m)
2023-06-30$31.54M(m)$27.83M$-82.20M(m)(m)(m)(m)(m)
2023-03-31$32.39M(m)$26.05M$-81.99M(m)(m)(m)(m)(m)
2022-12-31$27.97M(m)$22.77M$-79.57M(m)(m)(m)(m)(m)
2022-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$15.51M(m)$4.57M$-32.01M(m)(m)(m)(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$9.44M(m)$154.00K$-13.90M(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.